Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study by Samantha C. Gouw, Johanna G. van der Bom, and H. Marijke van den Berg Blood Volume 109(11):4648-4654 June 1, 2007 ©2007 by American Society of Hematology
Cumulative incidence of inhibitor development: all inhibitors, and high- and low-titer inhibitors. Samantha C. Gouw et al. Blood 2007;109:4648-4654 ©2007 by American Society of Hematology
Cumulative incidence of inhibitor development according to treatment regimen: prophylaxis versus on demand. Cumulative incidence of inhibitor development according to treatment regimen: prophylaxis versus on demand. Samantha C. Gouw et al. Blood 2007;109:4648-4654 ©2007 by American Society of Hematology